Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research in the pharmaceutical sector in Newbury.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department funds research and research infrastructure, which supports patients and the public to participate in high-quality research across the United Kingdom, through the National Institute of Health and Care Research (NIHR).
Development and delivery of research in the pharmaceutical sector is supported and enabled nationwide through NIHR infrastructure, including the NIHR Research Delivery Network (RDN), the NIHR Clinical Research Facilities (CRFs), the NIHR Biomedical Research Centres (BRCs), and the newly designated NIHR Commercial Research Delivery Centres (CRDCs). These all support the delivery of clinical research through facilities, staff resource, collaborations, and funding.
In Newbury, pharmaceutical research benefits from the South Central RDN, as well as the Oxford and Southampton-based CRFs and BRCs, and from April, a new CRDC in Southampton, all of which support a range of pharmaceutical studies in the region.
In order to maximise our potential to be a world leader and develop a more competitive, efficient, and accessible clinical research system, the Department is committed to implementing the recommendations from Lord O'Shaughnessy’s independent review of commercial clinical trials in full. We expect these efforts to attract more commercial investment in clinical research and yield a broad and diverse portfolio of clinical trials in the United Kingdom, to provide innovative treatment options for patients.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the Pharmacy First campaign.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is a targeted public communications campaign with associated media materials, running from 11 November 2024 until mid-December 2024 as well as coordinated communications across the healthcare system and sharing best practices where the service is already working well.
Action is also being taken to drive further engagement and referrals from general practice, with targeted engagement through regional and integrated care board (ICB) channels and regular data to support managing performance. In addition to this, funding has been provided to ICBs to recruit primary care network engagement leads who will be well placed to support practice teams to refer into the service.
Additionally, NHS England is improving digital systems to make the referral process better integrated, including further development of electronic referral systems. Most pharmacies can now also receive Pharmacy First referrals from general practitioners straight into their NHS England assured pharmacy IT systems.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the provision of adequate (a) palliative and (b) end-of-life care in Newbury.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Palliative care services are included in the list of services that integrated care boards (ICBs), including Buckinghamshire, Oxfordshire and Berkshire West ICB, which covers the Newbury constituency, must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.
NHS England has also developed a palliative and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of those their local population, thereby enabling ICBs to put plans in place to address and track the improvement of health inequalities.
I met NHS England and discussions have begun on how to reduce inequalities and variation in access to, and the quality of, palliative and end of life care.
Additionally, we have committed to develop a 10-Year Health Plan, to deliver a National Health Service fit for the future, as part of which we will carefully be considering policies, including those that impact people with palliative and end of life care needs, with input from the public, patients, health staff, and our stakeholders as we develop the plan. More information about how they can input into the 10-Year Health Plan is available at the following link:
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will conduct a review of the decision to delegate the power to hold leases for GP premises to integrated care boards.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England currently accepts ICBs holding leases only as a last resort or by exception due to the significant capital required. While we know that is not the most effective use of ICB resources, it is an important safeguard. We are committed to fixing the front door of the NHS by supporting GPs and ICBs through, for example, the £100 million of capital funding announced at the Budget for GP estate upgrades.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to paragraph 2.40 of the Autumn Budget 2024, HC 295, published on 30 October 2024, what assessment he has made of the potential impact of the rise in the rate of employer national insurance contributions on pharmacies.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We have taken tough decisions to fix the foundations in the public finances at Autumn Budget. This enabled the Spending Review settlement of a £22.6 billion increase in resource spending for the Department from 2023/24 outturn to 2025/26. The employer national insurance rise will be implemented April 2025, the Department will set out further details on allocation of funding for next year in due course.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the clean air policy addresses the risks of (a) carbon monoxide and (b) other indoor air pollutants.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) works in partnership with other organisations to develop advice and recommended actions which can improve detection of, and prevent accidental exposure to, carbon monoxide in homes. This includes participating in a cross-Government group on gas safety and carbon monoxide awareness, which promotes a joined-up approach to improving gas safety and reducing carbon monoxide poisoning risks.
The UKHSA Clean Air Programme includes efforts both to build the evidence base and raise awareness of indoor air quality and its health impacts. Furthermore, the National Institute for Health and Care Excellence has published guidance on indoor air quality at home, designed to raise awareness of the importance of good air quality in people's homes and advise on how to achieve this.
Building regulations already require that carbon monoxide alarms are fitted alongside the installation of fixed combustion appliances of any fuel type, excluding gas cookers, in all tenures. The ingress of outdoor air can affect indoor air quality, and the Government is committed to delivering a comprehensive and ambitious Clean Air Strategy.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking with Cabinet colleagues to provide adequate funding for research into blood cancer (a) treatment and (b) care; and what steps he is taking to help tackle delays in blood cancer diagnosis.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department funds research into blood cancer through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group.
In blood cancer research, the NIHR is funding the £2.6 million PROPEL trial, testing whether a package of enhanced personalised prehabilitation can help people with acute myeloid leukaemia cope better with treatment. The NIHR is also funding a £3 million trial of the drug ibrutinib for treatment of chronic lymphocytic leukaemia, and a £2.2 million study to evaluate the digital health platform, AscelusTM, for management of blood disorders, including cancers.
The NIHR welcomes funding applications for research into any aspect of human health, including all cancers. As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
We are committed to improving cancer survival rates and hitting all National Health Service cancer waiting time standards within five years, so no patient waits longer than they should. We will also address the challenges in diagnostic waiting times, providing the number of computed tomography, magnetic resonance imaging, and other tests that are needed to reduce waits.
We are committed to achieving the Faster Diagnosis Standard, which aims to ensure patients have cancer diagnosed or ruled out within 28 days of referral from a general practice (GP) or screening services. We are expanding direct access to diagnostic scans across all GPs, helping to cut waiting times and speeding up a cancer diagnosis or all-clear for patients.
The NHS is implementing non-specific symptom pathways for patients who present with vague and non-specific symptoms, which do not clearly align to a cancer type. This aims to reduce the delays experienced by some patients, and are expected to be of particular benefit to people presenting with signs and symptoms that could be due to blood cancer.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of taking steps to increase the number of clinical academics dedicated to blood cancer research.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department, through the National Institute for Health and Care Research (NIHR), is the largest funder of clinical academic training in the United Kingdom, delivering a comprehensive research career pathway for the full range of clinicians. The NIHR welcomes applications for training awards from the clinical and non-clinical academic workforce conducting research into any aspect of human health, including blood cancer. The NIHR continuously reviews the training offer to identify and address gaps across specialism, geography, and profession, in line with the Department’s priorities.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that new parents receive adequate support.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has an ambition to achieve the healthiest generation of children ever. A strong child health focus will need to underpin both the Health and Opportunity Missions.
The zero- to five-year-olds element of the Healthy Child Programme is a universal, personalised service, led by health visitors and family nurses, for new parents, and reaches 97% of families. Every family should be offered five visits, including antenatal and new birth contact, alongside targeted support for families who require additional help. £3.6 billion was allocated to local authorities through the Public Health Grant in 2024/25, which is used to fund the delivery of the Healthy Child Programme.
The Family Hubs and Start for Life Programme provides support for babies and their families in the critical 1,001 days from conception to the age of two. It provides approximately £300 million over three years to 75 local authorities in England with high levels of deprivation to create a network of Family Hubs, with Start for Life services at its core. Support for new parents and carers with babies includes: perinatal mental health support and services, to promote positive early relationships; face-to-face and virtual infant feeding services; and increased capacity for the National Breastfeeding Helpline.
The Healthy Start scheme, introduced in 2006, encourages a healthy diet for pregnant women, babies, and young children under four years old from very low-income households.
Asked by: Lee Dillon (Liberal Democrat - Newbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to support NHS services in Newbury, in the context of his Department's review of the New Hospital Programme.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises that delivering high quality National Health Services requires the right facilities and support systems in the right places. We understand that investment in capital projects, whether through allocations prioritised locally or through national programmes, is important in achieving this.
We inherited a New Hospital Programme which was delayed and the funding for which ran out in March. We are reviewing it to provide people in Newbury and across the country with a realistic and costed timetable for delivery. Newbury is served by the Royal Berkshire Hospital scheme which is in scope of the review. The review is feeding into the Spending Review process where the Government will confirm the outcome.
Managing the local capital budget for its area and reconfiguring services, which includes addressing estates issues, as well as allocating funds according to local priorities, including investment to support healthcare services, are matters for local NHS organisations. Any future national capital programmes to support NHS organisations delivering local and national priorities will also be considered as part of the Spending Review process.